M&A Deal Summary |
|
|---|---|
| Date | 2013-02-01 |
| Target | Natur Produkt |
| Sector | Life Science |
| Buyer(s) | Bausch Health |
| Deal Type | Add-on Acquisition |
| Deal Value | 163M USD |
SEARCH BY
| Category | Company |
|---|---|
| Sector | Life Science |
| Employees | 20,270 |
| Revenue | 9.6B USD (2024) |
Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.
| DEAL STATS | # |
|---|---|
| Overall | 22 of 36 |
| Sector: Life Science M&A | 16 of 22 |
| Type: Add-on Acquisition M&A Deals | 15 of 26 |
| Country: Russia M&A | 1 of 1 |
| Year: 2013 M&A | 1 of 4 |
| Size (of disclosed) | 20 of 28 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-12-11 |
Medicis Pharmaceutical
Scottsdale, Arizona, United States Medicis Pharmaceutical Corporation is a pharmaceutical company in the United States focusing primarily on the treatment of dermatological and aesthetic conditions. |
Buy | $2.6B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2013-03-20 |
Obagi
Long Beach, California, United States Obagi is a physician-dispensed brand in the dermo-cosmetic space, the highest-growth category in skin care. Obagi's product portfolio includes brands Obagi Nu-Derm®, Condition & Enhance®, Obagi-C® Rx, ELASTIDerm® and CLENZIDerm®. |
Buy | $360M |
